Gregory D. Chapman, MD, FACC is a Professor of Medicine/Cardiovascular Disease at the University of Alabama at Birmingham. He has published commentaries and research papers in The New England Journal of Medicine, Circulation, the American Journal of Cardiology, and the American Journal of Medicine. He is now in his third decade of practice as a cardiologist, with experience in academic and private practice settings. His interests include STEMI recognition and treatment, as well as the diagnosis of acute coronary syndromes and their mimics. In addition to an active clinical role, he enjoys teaching residents in internal medicine, emergency medicine, and cardiology
Acute coronary artery syndromes; primary angioplasty and stenting for acute myocardial infarction; restenosis post-PCI; investigational devices, including drug-eluting stents; angiogenesis; cardiovascular gene transfer and gene therapy; troponin use in clinical practice
Dr. Fry has a BS in Microbiology, MS in Molecular Biology and Medical Degree all earned at the University of Arizona. He completed his Post graduate training at Banner Health and St Joseph’s Medical Center in the Phoenix metropolitan area. He has been in general practice in the Scottsdale, Arizona since 1992 and has had a special clinical interest in CFS, autoimmune and vascular disease. He has lectured nationally and has numerous publications, abstracts, and patents. His science interests are in the microbial causation of chronic disease, biofilms, and their treatment. Because of these interests Dr. Fry has worked on new methods for disease detection which have culminated in the development of a Next -Gen Sequencing system for microbial identification. Dr. Fry is the founder of Fry Laboratories LLC, a CLIA clinical diagnostic laboratory that participates in CAP and API validation systems. The laboratory specializes in the vector borne diseases, molecular methods of detection of prokaryotes, archaea, protozoans, and fungi. Dr. Fry enjoys family time and has a private pilots license, is an avid skier, sailor and bicyclist.
Diseases of Interest: Chronic Fatigue Syndrome, Fibromyalgia, Gulf War Veterans Illness, Chronic Lyme Disease, ALS (Lou Gehrig’s Disease), Parkinson’s Disease, Multiple Sclerosis, Lupus, Scleroderma, Rheumatoid Arthritis, Osteoarthritis, and Vascular Disease. Organisms of Interest: Borrelia (Lyme), Babesia, Bartonella, Anaplasma, Ehrlichia, Coxiella (Q-Fever), Toxoplasma, Rickettsia, Plasmodium, and Novel Biofilm Forming Protozoa.
Dr. Behruzi is an assistant professor at McGill University, Department of Family Medicine, and a clinician researcher in the Research Center at CISSS in Outaouais. She has more than 20 years of experience in both teaching and clinical research. She has a Master’s degree (MSc) in Midwifery and she completed a PhD in Public Health at the University of Montreal, during which she obtained many awards and bursary from CIHR, STIRRHS, Bourse Étude Supériour en Santé Publique, and Japan Society for the Promotion of Science (JSPS) Fellowship. In 2008, she accomplished a fellowship in Japan on maternity care services. She also accomplished three years postdoctoral fellowship at the department of Family Medicine at McGill University, for which, she was awarded two times the Fond de Recherche en Santé du Québec (FRSQ). She collaborates with GCP Trials center in Montreal, in where, she provide workshops in Good clinical practice for clinical research staff. Her latest research interest is working on the safety and efficacy of Probiotics on Group Streptococcus (GBS) Rectovaginal Colonization in Pregnancy.
Her latest research interest is working on the safety and efficacy of Probiotics on Group Streptococcus (GBS) Rectovaginal Colonization in Pregnancy.
Farah Ahmad, MBBS, MPH, PhD is Associate Professor at the School of Health Policy and Management, York University and affiliate Research Scientist at the North York General Hospital. Her training includes family medicine and public health sciences. She conducts health services research with a focus on psychosocial health vulnerable communities, primary care and eHealth innovations. She has extensively published in the areas of underserved populations, mental health and partner violence.
Current Research: eHealth to Transform Healthcare
Dr.Senderovich is a physician at Baycrest Health Science System with practice focused on Palliative Care, Pain Medicine and Geriatrics. She is an Assistant Professor at the Department of Family and Community Medicine, and Division of Palliative Care at the University of Toronto who actively involved teaching medical students and residents. She has a broad international experience and a solid research background. Her research was accepted nationally and internationally. She is an author of multiple manuscripts focused on geriatrics, patient’s centered care, ethical and legal aspect of doctor patient relationship, palliative and end-of-life care. She recently published a book on Integration of Palliative Care in Congestive Heart Failure which is available on amazon.com link for the book: https://www.amazon.com/Integrated-life-Advanced-CongestiveFailure/dp/3330652799/ref=sr_1_1?s=books&ie=UTF8&qid=1497677617&sr=11&keywords=Integrated+End-of-life+Care+in+Advanced+Congestive+Heart+Failure and A chapter to Book : Horizons in World Cardiovascular Research. Volume 13 on Integration of Palliative Care in Congestive Heart Failure management. Where are we now ? https://www.novapublishers.com/catalog/product_info.php?products_id=62983
Health Policy, Knowledge Translation, Alzheimer's/Dementia, Polypharmacy, Palliative Care, Public Health, Quality Improvement, Quality of Life/Satisfaction, Observational (e.g., cohort, case-control), Systematic Reviews, Qualitative Data Analysis, Cancer Care, Family Caregivers, Chronic Diseases (e.g., COPD,CHF,Dementia ), Geriatrics and Pain Medicine